{"id":780555,"date":"2026-07-05T12:31:10","date_gmt":"2026-07-05T12:31:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/780555\/"},"modified":"2026-07-05T12:31:10","modified_gmt":"2026-07-05T12:31:10","slug":"ebola-treatment-trial-begins-in-congo-as-outbreak-continues-to-grow","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/780555\/","title":{"rendered":"Ebola treatment trial begins in Congo as outbreak continues to grow"},"content":{"rendered":"<p class=\"paragraph_paragraph___QITb\">A trial for an experimental Ebola treatment has started in Congo, where the largest-ever Ebola outbreak continues to grow.<\/p>\n<p class=\"paragraph_paragraph___QITb\">Researchers begun the study of two possible treatments on Thursday at the Ebola treatment centre inside Bunia&#8217;s Evangelical Medical Center, in eastern Congo&#8217;s Ituri province.\u00a0<\/p>\n<p><img decoding=\"async\" alt=\"A woman walks past a pale yellow building with a sign that indicates it is a medical facility\" class=\"Image_image__5tFYM ContentImage_image__DQ_cq\"  src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/07\/88e02ad5ee77e4e08d443b302314d748.jpeg\" loading=\"lazy\" data-component=\"Image\" data-lazy=\"true\"\/><\/p>\n<p class=\"Typography_base__sj2RP FigureCaption_text__zDxQ5 Typography_sizeMobile12__w_FPC Typography_lineHeightMobile20___U7Vr Typography_regular__WeIG6 Typography_colourInherit__dfnUx\" data-component=\"Typography\">Some Bunia residents have welcomed the trials, while others are voicing their distrust.\u00a0 (Dirole Lotsima Dieudonne\/AP)<\/p>\n<p class=\"paragraph_paragraph___QITb\">Two drugs will be tested to see if they could improve survival.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">One is Gilead Sciences&#8217;s remdesivir, a broad-acting antiviral. It was approved to treat COVID-19 but has shown some hints in lab tests that it may help fight Bundibugyo, the virus causing the current Ebola outbreak.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">The other is Mapp Biopharmaceutical&#8217;s experimental MBP134, which is made of antibodies engineered to target Ebola viruses including Bundibugyo.<\/p>\n<p class=\"paragraph_paragraph___QITb\">Researchers will test whether either, or a combination of both, can improve survival among infected patients.\u00a0<\/p>\n<p><a href=\"https:\/\/www.abc.net.au\/news\/2026-06-24\/congo-ebola-outbreak-worst-ever-recorded\/106832916\" data-component=\"FullBleedLink\" class=\"RelatedCard_link__rsgR9 FullBleedLink_root__lTw_U interactive_focusContext__yRhc_ interactive_defaults__AKxUU FullBleedLink_showVisited__g3Xvz\" rel=\"nofollow noopener\" target=\"_blank\">Ebola virus outbreak grows<\/a><\/p>\n<p class=\"Typography_base__sj2RP RelatedCard_synopsis__cFwMW Typography_sizeMobile14__u7TGe Typography_lineHeightMobile20___U7Vr Typography_regular__WeIG6 Typography_colourInherit__dfnUx\" data-component=\"Typography\">There are now more than 1,000 confirmed cases of Ebola in the Democratic Republic of Congo and 267 people have died, local officials say.<\/p>\n<p class=\"paragraph_paragraph___QITb\">On Thursday, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus announced more than 1,400 people have been diagnosed and 438 have died from Bundibugyo.<\/p>\n<p class=\"paragraph_paragraph___QITb\">The trial &#8220;offers real hope that we can deliver concrete results for, and with, the communities at the heart of the outbreak,&#8221; Dr Tedros said in a statement.<\/p>\n<p>More participants needed<\/p>\n<p class=\"paragraph_paragraph___QITb\">WHO research adviser Vasee Moorthy said the trial could take months, with possibly as many as 1,000 participants to tell if either drug works.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">But if one or the other drug is shown to be highly effective, scientists will be able to tell more quickly and with fewer patients, he said.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">After a participant begins the trial, survival will be tracked for 28 days after starting treatment.\u00a0<\/p>\n<p><img decoding=\"async\" alt=\"A man with his eyes closed is carried on a mattress into an ambulance with people watching on, wearing masks.\" class=\"Image_image__5tFYM ContentImage_image__DQ_cq\"  src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/07\/ac9baca7aa8ccba329ba6b49e4e5656a.jpeg\" loading=\"lazy\" data-component=\"Image\" data-lazy=\"true\"\/><\/p>\n<p class=\"Typography_base__sj2RP FigureCaption_text__zDxQ5 Typography_sizeMobile12__w_FPC Typography_lineHeightMobile20___U7Vr Typography_regular__WeIG6 Typography_colourInherit__dfnUx\" data-component=\"Typography\">The Bundibugyo strain has no vaccine or specific treatment and has a high fatality rate. (Reuters: Victoire Mukenge)<\/p>\n<p class=\"paragraph_paragraph___QITb\">A second phase of the trial will include healthcare workers, close contacts and others at high risk of infection.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">Depending on how quickly the outbreak evolves, the research could continue for six or more months, Professor Placide Mbala said, the coordinator of laboratory activities for the current outbreak.<\/p>\n<p class=\"paragraph_paragraph___QITb\">The current trial is a collaboration between Congo&#8217;s national biomedical research institute INRB, Britain&#8217;s Oxford University, Antwerp&#8217;s Institute of Tropical Medicine and other international health groups.<\/p>\n<p>Hopes for relief<\/p>\n<p class=\"paragraph_paragraph___QITb\">Some Bunia residents welcome the trial, while others are voicing their distrust.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">For Audrey Tengetenge, the trials represent a &#8220;light at the end of the tunnel&#8221;.<\/p>\n<p class=\"paragraph_paragraph___QITb\">&#8220;I hope everything moves very quickly so that we can find relief. We want nothing more than an end to this very dangerous disease, which continues to bring us grief,&#8221; Ms Tengetenge said.<\/p>\n<p class=\"paragraph_paragraph___QITb\">Another resident, Gladys Munguro, is also hopeful about the new study.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">Ms Munguro survived Ebola and was discharged from an Ebola treatment centre two weeks ago, where she said she watched fellow patients die from the disease.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">&#8220;This experimental phase is necessary for us,&#8221; Ms Munguro told The Associated Press.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">&#8220;I will volunteer as soon as the next phase of the trials begins for high-risk individuals.&#8221;<\/p>\n<p><a href=\"https:\/\/www.abc.net.au\/news\/2026-06-01\/ebola-australia-travel-restrictions-mark-butler\/106745230\" data-component=\"FullBleedLink\" class=\"RelatedCard_link__rsgR9 FullBleedLink_root__lTw_U interactive_focusContext__yRhc_ interactive_defaults__AKxUU FullBleedLink_showVisited__g3Xvz\" rel=\"nofollow noopener\" target=\"_blank\">Australia won&#8217;t impose travel restrictions despite overseas Ebola spread<\/a><\/p>\n<p class=\"Typography_base__sj2RP RelatedCard_synopsis__cFwMW Typography_sizeMobile14__u7TGe Typography_lineHeightMobile20___U7Vr Typography_regular__WeIG6 Typography_colourInherit__dfnUx\" data-component=\"Typography\">The federal government will not impose border restrictions on travellers from Ebola-stricken countries despite new suspected cases in Italy and Brazil.<\/p>\n<p class=\"paragraph_paragraph___QITb\">Others are concerned that the treatments could be the cause of more deaths.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">&#8220;Research should be carried out first and foremost on our elected representatives, as they are the ones who represent us,&#8221; Nelson Dhebi, a shopkeeper in Bunia, said.\u00a0<\/p>\n<p class=\"paragraph_paragraph___QITb\">Officials plan to expand the trials to other locations once it is safe to do so.<\/p>\n<p class=\"paragraph_paragraph___QITb\">AP<\/p>\n","protected":false},"excerpt":{"rendered":"A trial for an experimental Ebola treatment has started in Congo, where the largest-ever Ebola outbreak continues to&hellip;\n","protected":false},"author":2,"featured_media":780556,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[64,63,336146,84608,137,1109,3854],"class_list":["post-780555","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-au","tag-australia","tag-bundibugyo","tag-ebola","tag-health","tag-trial","tag-world-health-organisation"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/780555","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=780555"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/780555\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/780556"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=780555"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=780555"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=780555"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}